Shares of CVS Health Corp. CVS shed 2.32% to $67.05 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to 5,667.56 and ...

The Washington Spirit say their partnership renewal with CVS Health is a "multimillion-dollar investment" among the most valuable NWSL deals.

CVS Health is reevaluating its role in healthcare as financial pressures mount. The company, along with other major retailers ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Investors are optimistic that the company can overcome its difficulties following last year’s 40% drop in its stock price, ...

CVS Health has received menopause-friendly accreditation as part of its commitment to supporting employees through the condition and their aging journeys.

CVS Health Corp. closed 17.46% below its 52-week high of $80.75, which the company achieved on March 28th.

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.

JPMorgan Chase & Co. was sued by employees who say the company’s prescription drug plan, run by CVS Health Corp., agreed to pay exorbitant prices for medications, driving up expenses for workers.

JPMorgan Chase & Co. was sued by employees who say the company’s prescription drug plan, run by CVS Health Corp., agreed to pay exorbitant prices for medications, driving up expenses for workers.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Shares of CVS Health Co. (NYSE:CVS – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one ratings firms that are covering the stock, Marketbeat reports. Three ...